On the Cover

Citation: Khan M, Walters LL, Li Q, Thomas DG, Miller JM, Zhang Q, Sciallis AP, Liu Y, Dlouhy BJ, Fort PE, Archer SM, Demirci H, Dou Y, Rao RC. Characterization and pharmacologic targeting of EZH2, a fetal retinal protein and epigenetic regulator, in human retinoblastoma. Lab Invest. 2015; 95(11):1278-90.

  1. Abalem MF, Eagle KA, Rao RC. Unilateral retinopathy in a patient with diabetes and coronary heart disease. BMJ. 2018 Jun 14;361:k170.
  2. Abalem MF, Rao PK, Rao RC. Nystagmus and platinum hair. JAMA. 2018 Jan 23;319(4):399-400.
  3. Thomas M, Rao RC, Johnson MW, Paulus YM. Re: Bressler et al.: Factors associated with worsening proliferative diabetic retinopathy in eyes treated with panretinal photocoagulation or ranibizumab. Ophthalmology. 2017 Dec;124(12):e87-e88.
  4. Hiniker A, Oakes SA, Rao RC. Bilateral choroidal metastases from pancreatic adenocarcinoma. Ophthalmology. 2017 Dec;124(12):1825.
  5. Abalem MF, Carricondo PC, Rao RC. Bullseye retinopathy from antiretroviral therapy. Ophthalmology. 2017 Oct;124(10):1539.
  6. Rao RC, Larson SA, Dlouhy BJ. Growth hormone deficiency, basal encephalocele, and morning glory anomaly. Ophthalmology. 2017 Oct;124(10):1531.
  7. Mao F, Wang L, Lu Q, Xiao L, Li X, He X, Rao RC, Li J, Dou Y, Sun Z. De novo mutations involved in post-transcriptional dysregulation contribute to six neuropsychiatric disorders. bioRxiv. 13 August 2017 [Preprint]
  8. Young KZ, Dedania VS, Rao RC. Acute-on-chronic: retinal artery occlusion following retinal vein occlusion. Ophthalmology. 2017; 124(8):1142.
  9. Choudhry NC, Golding J, Rao RC. Widefield swept-source OCT of retinal capillary hemangioblastoma. Ophthalmology Retina. 2017 Jul-Aug;1(4):321.
  10. Rao RC, Dedania VS, Johnson MW. Stem cells for retinal disease: a perspective on the promise and perils. American Journal of Ophthalmology. 2017; 179:32-38.
  11. Cani AK, Hovelson DH, Demirci H, Johnson MW, Tomlins SA, Rao RC. Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies. Oncotarget. 2017; 8(5):7989-7998.
  12. Choudhry N, Golding J, Rao RC. Vitreous invasion: neovascular frond in proliferative diabetic retinopathy. Ophthalmology. 2016; 123(12):2625.
  13. Rao RC, Choudhry N. A christmas tree cataract. Can J Ophthalmol. 2016; 51(6):e160-e161.
  14. Avedschmidt SE, Stagner AM, Eagle RC Jr, Harocopos GJ, Dou Y, Rao RC. The targetable epigenetic tumor protein EZH2 is enriched in intraocular medulloepithelioma. Invest Ophthalmol Vis Sci. 2016; 57(14):6242-6246.
  15. Yan N, Cheng L, Cho K, Malik MT, Xiao L, Guo C, Yu H, Zhu R, Rao RC, Chen DF. Postnatal onset of retinal degeneration by loss of embryonic Ezh2 repression of Six1. Scientific Reports. 2016; 6:33887.
  16. Rao RC, Harbour JW. An iris tumor. JAMA Ophthalmology. 2016; 134(9):1063-4.
  17. Choudhry N, Golding J, Rao RC. In the fold of a macular hole. Ophthalmology. 2016; 123(9):1998.
  18. Choudhry N, Golding J, Rao RC. Cataractous mountain on the corneal horizon: swept-source optical coherence tomography. J Cataract Refract Surg. 2016; 42(7):1097.
  19. Rao RC, Chan MP, Andrews CA, Kahana A. EZH2, proliferation rate, and aggressive tumor subtypes in cutaneous basal cell carcinoma. JAMA Oncology. 2016; 2(7):962-3.
  20. Cani AK, Soliman M, Hovelson DH, Liu CJ, McDaniel AS, Haller MJ, Bratley JV, Rahrig SE, Li Q, Briceño CA, Tomlins SA, Rao RC. Comprehensive genomic profiling of orbital and ocular adnexal lymphomas identifies frequent alterations in MYD88 and chromatin modifiers: new routes to targeted therapies. Mod Pathol. 2016; 29(7):685-97.
  21. Khan M, Rao PK, Rao RC. A brushfire in the eye. BMJ. 2016; 353:i3075.
  22. Choudhry N, Golding J, Rao RC. Seeing through walls: subhyaloid hemorrhage. Ophthalmology. 2016; 123(6):1172.
  23. Ghodasra DH, Fante R, Gardner TW, Langue M, Niziol LM, Besirli C, Cohen SR, Dedania VS, Demirci H, Jain N, Jayasundera KT, Johnson MW, Kalyani PS, Rao RC, Zacks DN, Sundstrom JM. Safety and feasibility of quantitative multiplexed cytokine analysis from office-based vitreous aspiration. Invest Ophthalmol Vis Sci. 2016; 57(7):3017-23.
  24. Choudhry N, Golding J, Manry MW, Rao RC. Ultra-widefield steering-based spectral-domain optical coherence tomography imaging of the retinal periphery. Ophthalmology. 2016; 123(6):1368-74.
  25. Zhou B, Wang J, Lee SY, Xiong J, Bhanu N, Guo Q, Ma P, Sun Y, Rao RC, Garcia BA, Hess JL, Dou Y. PRDM16 suppresses MLL1r leukemia via intrinsic histone methyltransferase activity. Mol Cell. 2016; 62(2):222-36.
  26. Zhang H, Gayen S, Xiong J, Zhou B, Shanmugam AK, Sun Y, Karatas H, Liu L, Rao RC, Wang S, Nesvizhskii AI, Kalantry S, Dou Y. MLL1 inhibition reprograms epiblast stem cells to naive pluripotency. Cell Stem Cell. 2016; 18(4):481-94.
  27. Rao RC, Choudhry N. Cystoid macular edema associated with chemotherapy. CMAJ. 2016 Feb 16;188(3):216. doi: 10.1503/cmaj.131080.
  28. Rao RC, Shah GK. Correspondence. Retina. 2016; 36(1):e2-3.
  29. Choudhry N, Rao RC. Enhanced depth imaging features of a choroidal macrovessel. Retin Cases Brief Rep. 2016 Winter;10(1):18-21.
  30. Khan M, Walters LL, Li Q, Thomas DG, Miller JM, Zhang Q, Sciallis AP, Liu Y, Dlouhy BJ, Fort PE, Archer SM, Demirci H, Dou Y, Rao RC. Characterization and pharmacologic targeting of EZH2, a fetal retinal protein and epigenetic regulator, in human retinoblastoma. Lab Invest. 2015; 95(11):1278-90.
  31. Rao RC, Gragoudas ES. Choroidal metastases from EML4-ALK-Positive non-small-cell lung adenocarcinoma. J Clin Oncol. 2015; 33(30):e112-4.
  32. Rao RC, Cohen SR, Mian SI. Silicone oil retention sutures for retinal detachment repair following traumatic aniridia, aphakia, and ruptured globe. JAMA Ophthalmol. 2015 Sep;133(9):e151433.
  33. Rao RC, Elner VM, Demirci H. A Red and Swollen Eyelid. JAMA Oncol. 2015 Jul 1;1(4):537-8.
  34. Choudhry N, Rao RC. Multimodal ultrawide-field imaging features in Waardenburg Syndrome. Ophthalmic Surg Lasers Imaging Retina. 2015 Jun;46(6):670-3.
  35. Rao RC, Dou Y. Hijacked in cancer: the KMT2 (MLL) family of methyltransferases. Nat Rev Cancer. 2015 Jun;15(6):334-46.
  36. Johnson MW, Fahim AT, Rao RC. Acute ocriplasmin retinopathy. Retina. 2015 Jun;35(6):1055-8.
  37. Patane PS, Krummenacher TK, Rao RC. Valsalva hemorrhagic retinopathy presenting as a rare cause of impaired vision after a general anesthetic-a case report and review of the literature. J Clin Anesth 2015 Jun;27(4):341-6.
  38. Rao RC, Ballard TN, Chen TC. Iris heterochromia and unilateral eyelash hypertrichosis. JAMA. 2015 May 19;313(19):1967-8.
  39. Rao RC, Khan M, Badiyan SN, Harbour JW. Gene expression profiling and regression rate of irradiated uveal melanomas. Ophthalmic Surg Lasers Imaging Retina. 2015 Mar;46(3):333-7.
  40. Thompson DA, Ali RR, Banin E, Branham KE, Flannery JG, Gamm DM, Hauswirth WW, Heckenlively JR, Iannaccone A, Jayasundera KT, Khan NW, Molday RS, Pennesi ME, Reh TA, Weleber RG, Zacks DN; Monaciano Consortium [including Rao RC]. Advancing therapeutic strategies for inherited retinal degeneration: recommendations from the Monaciano Symposium. Invest Ophthalmol Vis Sci. 2015 Feb 9;56(2):918-31.
  41. Rao RC, Choudhry N. Enhanced depth imaging spectral-domain optical coherence tomography findings in choroidal neurofibromatosis. Ophthalmic Surg Lasers Imaging Retina. 2014 Sep-Oct;45(5):466-8.
  42. Khan M, Rao PK, Rao RC. Shimmering lights. JAMA Ophthalmol. 2014 Aug;132(8):1015-6.
  43. Dlouhy BJ, Awe O, Rao RC, Kirby PA, Hitchon PW. Autograft-derived spinal cord mass following olfactory mucosal cell transplantation in a spinal cord injury patient: Case report. J Neurosurg Spine. 2014 Oct;21(4):618-22.
  44. Rao RC, Choudhry N, Apte RS. Subconjunctival bevacizumab for iris neovascularisation - Authors' reply. Lancet Diabetes Endocrinol. 2014 Jun;2(6):450-1.
  45. Rao RC, Zacks DN. Cell and gene therapy. Dev Ophthalmol 2014;53:167-77.
  46. Rao RC, Dlouhy BJ. Stem cells and cardiovascular drug development. JAMA. 2014 Mar 12;311(10):1070.
  47. Choudhry N, Rao RC. Valsalva retinopathy. N Engl J Med 2014 Feb 20;370(8):e13.
  48. Rao RC, Choudhry N, Apte RS. Regression of iris neovascularization secondary to diabetic retinopathy following subconjunctival anti-VEGF therapy. Lancet Diabetes Endocrinol. 2014;2(2):182.
  49. Badiyan SN, Rao RC, Apicelli AJ, Acharya S, Verma V, Garsa AA, DeWees T, Garcia-Ramirez J, Grigsby PW, Harbour JW. Outcomes of iodine-125 plaque brachytherapy for uveal melanoma with intraoperative ultrasonography and supplemental transpupillary thermotherapy. Int J Radiat Oncol Biol Phys. 2014 Mar 15;88(4):801-5.
  50. Dlouhy BJ, Rao RC. Comment on: Surgical skill and complication rates after bariatric surgery. N Engl J Med 2014;370(3):285.
  51. Rao RC, Blinder KJ, Smith BS, Shah GK. Internal limiting membrane peeling for primary rhegmatogenous retinal detachment repair. Ophthalmology. 2013;120(5):1102-3.
  52. Rao RC, Dlouhy BJ. Comment on: Mechanisms and management of retinopathy of prematurity. N Engl J Med 2013;368(12):1161.
  53. Rao RC, Dlouhy BJ. Comment on: Fracture risk after cataract surgery. JAMA. 2012;308(21):2185.
  54. Rao RC, Dlouhy BJ. Comment on: Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes. N Engl J Med. 2012;367(21):2053.
  55. Rao RC, Dlouhy BJ. Comment on: Exposure to fireworks and eye injuries. JAMA. 2012;308(15):1523-4.
  56. Rao RC, Dlouhy BJ. Comment on: Retinal detachment and fluoroquinolones. JAMA. 2012;308(3):233.
  57. Rao RC, Dlouhy BJ. Comment on: Diabetic retinopathy. N Engl J Med. 2012;367(2):184.
  58. Rao RC, Dlouhy BJ. Comment on: Shortening medical training. JAMA. 2012;308(2):133-4.
  59. Dlouhy BJ, Rao RC. Comment on: Amantadine for severe traumatic brain injury. N Engl J Med. 2012;366(25):2427.
  60. Rao RC, Choudhry N, Gragoudas ES. Enhanced depth imaging spectral-domain optical coherence tomography findings in sclerochoroidal calcification. Retina. 2012;32(6):1226-7.
  61. Dlouhy BJ, Rao RC. Comment on: Memory enhancement and deep brain stimulation of entorhinal area. N Engl J Med. 2012;366(20):1945-6.
  62. Rao RC, Hennig A, Malik MTA, Chen DF, Chen S. Chromatin modifications in retinal gene expression, development, and disease. J Ocul Biol Dis Infor. 2011;4:121-36.
  63. Rao RC, Poole Perry LJ. Decreased vision following eye trauma. JAMA. 2011;306(23):2606-7.
  64. Jakobiec FA, Zakka FR, D’Amato RJ, DeAngelis MM, Walton DS, Rao RC. Unilateral sporadic retinal dysplasia: results of histopathologic, immunohistochemical, chromosomal, genetic and VEGF-A analyses. J AAPOS. 2011;15(6):579-86.
  65. Rao RC, Chen DF, Miller JW. An epigenetic approach toward understanding ocular alpha-herpesvirus pathogenesis and treatment. Int Ophthalmol Clin. 2011; 51(4):117-33.
  66. Rao RC, Tchedre KT, Malik MTA, Fang Y, Coleman N, Marquez VE, Chen DF. Histone methylation in the developing retina. Invest Ophthalmol Vis Sci. 2010;51(12):6784-92.
  67. Rao, RC. Alternatives to embryonic stem cells and cloning: a brief scientific overview. Yale J Health Policy Law Ethics. 2009;9(2):603-22.
  68. Rao RC, Boyd J, Padmanabhan R, Chenoweth JG, McKay RD. Efficient serum-free derivation of oligodendrocyte precursors from neural stem cell-enriched cultures. Stem Cells. 2009;27(1):116-25.